Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines (Q46614656)

23 December 2017

title

Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines (English)

1 reference

23 December 2017

1 reference

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

3

Timothy F Murphy

1 reference

23 December 2017

Tinghuai Wu

1

1 reference

23 December 2017

Jing Chen

series ordinal

2

1 reference

23 December 2017

Bruce A Green

series ordinal

4

1 reference

23 December 2017

Xin-Xing Gu

series ordinal

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

23 December 2017

published in

Vaccine

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

44

1 reference

23 December 2017

page(s)

5177-5185

1 reference

23 December 2017

Respiratory infections caused by non-typeable Haemophilus influenzae

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Carrier-priming leads to hapten-specific suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Identification of a specific epitope of Haemophilus influenzae on a 16,600-dalton outer membrane protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Local Antibody Response to P6 of NontypableHaemophilus influenzaein Otitis-prone and Normal Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Colorimetric Method for Determination of Sugars and Related Substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.014

7 January 2021

10.1016/J.VACCINE.2005.06.014

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017